StockpollyBeta
Get App
Delisting riskPopularity #3,854
SNYR · NASDAQ · Medical - Distribution

Synergy CHC (SNYR)

Consumer-health owner of FOCUSfactor supplements and Flat Tummy wellness products.

$0.0905
vs last close0.00 (0.00%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions5.66%589.4K shares
14 holders · as of Jun 30, 2026
Insiders11.07%1.15M shares
4 holders · as of Apr 24, 2026
Strategic holders18.37%1.91M shares
1 holder · as of Jun 13, 2025
Other64.90%6.75M shares
remainder

10.41M company shares as of Sep 19, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (14.90M in the company's Sep 22, 2026 report, 10.41M elsewhere); stakes use the report.

13F · 13D/G · Form 4

HolderStakeSharesDate
Knight Therapeutics Inc1Strategic10 percent owner
18.37%1.91Mfiled Jun 13, 2025
Jack RossInsiderdirector, 10 percent owner, officer: CEO and Chairman
6.83%710,507filed Jul 31, 2025
Nitin KaushalInsiderdirector
2.94%306,433filed Apr 24, 2026
Jane Street Group, LLCInstitution
1.75%181,648as of Jun 30, 2026
Act Advisors, LLC.Institution
1.46%151,840as of Jun 30, 2026
James Paul SoRelleInsiderdirector
1.05%108,963filed Oct 22, 2024
XTX Topco LtdInstitution
0.59%61,270as of Jun 30, 2026
Vanguard Capital Management LLCInstitution
0.37%38,909as of Jun 30, 2026
HRT Financial LPInstitution
0.33%34,035as of Jun 30, 2026
Geode Capital Management, LLCInstitution
0.31%32,775as of Jun 30, 2026
Teresa Brigid ThompsonInsiderdirector
0.25%25,824filed Apr 23, 2026
Virtu Financial LLCInstitution
0.18%18,539as of Jun 30, 2026
Vanguard Fiduciary Trust CoInstitution
0.15%16,008as of Jun 30, 2026
Stonex Group Inc.Institution
0.15%15,109as of Jun 30, 2026
Ewa, LLCInstitution
0.13%13,727as of Jun 30, 2026
Citadel Advisors LLCInstitution
0.10%10,902as of Jun 30, 2026
Williams & Novak, LLCInstitution
0.10%10,020as of Jun 30, 2026
Tower Research Capital LLC (TRC)Institution
0.04%3,714as of Jun 30, 2026
Barclays PLCInstitution
0.01%884as of Jun 30, 2026
Schedule 13dInsider
—14.00% of class, as filed—filed Oct 31, 2024
Sanders Morris LLCInstitution
—5.24% of class, as filed—filed Oct 25, 2024
Knight Therapeutics (Barbados) Inc.2Strategic10 percent owner
15.41%1.60Mfiled Dec 23, 2016
Jeffrey Kadanoff3Insiderofficer: Chief Financial Officer
0.44%45,455filed Nov 1, 2017
  1. Knight Therapeutics Inc's transaction reports restate only vehicles that traded; the 2025 ownership statement (1.91M) is used instead.
  2. Last filed Dec 23, 2016; leaving the company requires no filing. Not in the bar.
  3. Last filed Nov 1, 2017; leaving the company requires no filing. Not in the bar.

13F, as of Jun 30, 2026

14 holders · 589.4K shares · 9 new positions · 11 increased · 3 reduced · 7 closed

HolderShares% outstandingChg q/qFiled
Jane Street Group, LLC181.6K1.75%+181.6KAug 14, 2026
Act Advisors, LLC.151.8K1.46%+151.8KnewJul 22, 2026
XTX Topco Ltd61.3K0.59%+61.3KnewAug 14, 2026
Vanguard Capital Management LLC38.9K0.37%−50.9KAug 13, 2026
HRT Financial LP34.0K0.33%+34.0KnewAug 14, 2026
Geode Capital Management, LLC32.8K0.31%+11.4KAug 12, 2026
Virtu Financial LLC18.5K0.18%+18.5KnewAug 13, 2026
Vanguard Fiduciary Trust Co16.0K0.15%−7.1KAug 13, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Knight Therapeutics Inc.19.90%1.91M13GJun 13, 2025
Schedule 13D14.00%13DOct 31, 2024
Sanders Morris LLC5.24%396.0KOct 25, 2024

Form 4

Latest trades

No open-market trades in the last 12 months.

House and Senate disclosures

Not reported.